<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-2448</journal-id>
<journal-title><![CDATA[Acta Medica Colombiana]]></journal-title>
<abbrev-journal-title><![CDATA[Acta Med Colomb]]></abbrev-journal-title>
<issn>0120-2448</issn>
<publisher>
<publisher-name><![CDATA[Asociacion Colombiana de Medicina Interna]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-24482020000100025</article-id>
<article-id pub-id-type="doi">10.36104/amc.2020.1386</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Microbiological diagnosis in febrile neutropenia secondary to chemotherapy for hematologicmalignancy. A cohort description]]></article-title>
<article-title xml:lang="es"><![CDATA[Diagnóstico microbiológico en neutropenia febril secundaria a quimioterapia por malignidad hematológica Descripción de una cohorte]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Rueda]]></surname>
<given-names><![CDATA[Karen Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Londoño-Castillo]]></surname>
<given-names><![CDATA[Juliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villegas-Sierra]]></surname>
<given-names><![CDATA[Laura Elisa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Gómez]]></surname>
<given-names><![CDATA[María Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Correa-García]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Clínica Las Vegas  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Antioquia  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Hospital de Primer Nivel de El Retorno  ]]></institution>
<addr-line><![CDATA[Guaviare ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>45</volume>
<numero>1</numero>
<fpage>25</fpage>
<lpage>31</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-24482020000100025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-24482020000100025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-24482020000100025&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: to describe the demographic, clinical, therapeutic and microbiological characteristics of patients with hematological malignancies undergoing chemotherapy who develop febrile neutropenia during treatment, as well as the mortality at discharge.  Methods: a retrospective cohort study of patients with hematologic neoplasms who developed febrile neutropenia and were seen at the Hospital Universitario San Vicente Fundación in Medellín.  Results: records of 110 episodes of febrile neutropenia were obtained. The mean age was 45 years. In 55.4%, a microbiological diagnosis was obtained; bacteremia was documented in 83.8% of these. The most common microorganisms wereK.pneumoniae(30%) andE. coli(18%). Antibiotic resistance due to ESBLs or carbapenemases ingram negativebacilli was 33%. Death occurred in 17% of patients. Acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) were the most prevalent underlying diagnoses; the most prevalent clinical focus was bacteremia (24.5%).  Conclusion: in our case series, there are significant differences in the percentage of patients with bacteremia, as well as in global mortality, compared to the rest of the cohorts in the region. A new research study needs to be carried out to clarify the source of these differences.(Acta Med Colomb 2020; 45. DOI:https://doi.org/10.36104/amc.2020.1386).]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: describir las características demográficas, clínicas, terapéuticas y microbiológicas de los pacientes con malignidad hematológica en quimioterapia que desarrollan neutropenia febril durante el tratamiento, así como la mortalidad al egreso.  Métodos: estudio de cohorte retrospectivo en pacientes con neoplasia hematológica que desarrollaron neutropenia febril evaluados en el Hospital Universitario San Vicente Fundación de Medellín.  Resultados: se obtuvo el registro de 110 episodios de neutropenia febril. Media de edad 45 años. En 55.4% se obtuvo diagnóstico microbiológico, la bacteriemia fue documentada en 83.8% de ellos. Los microorganismos más comunes fueronK.pneumoniae(30%) yE. coli(18%). La resistencia a antibióticos por presencia de BLEE o carbapenemasas en bacilosgram negativosfue de 33%. La mortalidad ocurrió en 17% de los pacientes. La leucemia linfoide aguda (LLA) y leucemia mieloide aguda (LMA) fueron los diagnósticos de base más prevalentes, el foco clínico más prevalente fue bacteriemia (24.5%).  Conclusión: en nuestra cohorte se encontró diferencias significativas en cuanto al porcentaje de pacientes con bacteriemia, así como en la mortalidad global respecto al resto de cohortes de la región, es necesario desarrollar un nuevo trabajo de investigación que permita aclarar el origen de estas diferencias.(Acta Med Colomb 2020; 45. DOI:https://doi.org/10.36104/amc.2020.1386).]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[chemotherapy]]></kwd>
<kwd lng="en"><![CDATA[microbiology]]></kwd>
<kwd lng="es"><![CDATA[quimioterapia]]></kwd>
<kwd lng="es"><![CDATA[microbiología]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ke]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frontiers in Laboratory Medicine Molecular targeted therapy of cancer The progress and future prospect]]></article-title>
<source><![CDATA[Front Lab Med]]></source>
<year>2017</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>69-75</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hassanpour]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Dehghani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review of cancer from perspective of molecular]]></article-title>
<source><![CDATA[J Cancer Res Pract]]></source>
<year>2017</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>127-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kurzrock]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxicity of targeted therapy Implications for response and impact of genetic polymorphisms]]></article-title>
<source><![CDATA[Cancer Treat Rev]]></source>
<year>2014</year>
<volume>40</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>883-91</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kurzrock]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding Toxicities of Targeted Agents_ Implications for Anti-tumor Activity and Management]]></article-title>
<source><![CDATA[Semin Oncol]]></source>
<year>2015</year>
<volume>42</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>863-75</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dy]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Adjei]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Understanding, Recognizing, and Managing Toxicities of Targeted Anticancer Therapies]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2013</year>
<volume>63</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>249-79</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Swati]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gita]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microbial Etiology of Febrile Neutropenia]]></article-title>
<source><![CDATA[Indian J Hematol Blood Transfus]]></source>
<year>2010</year>
<volume>26</volume>
<numero>June</numero>
<issue>June</issue>
<page-range>49-55</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samonis]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Vardakas]]></surname>
<given-names><![CDATA[K.Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Maraki]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies]]></article-title>
<source><![CDATA[Support Care Cancer]]></source>
<year>2013</year>
<volume>21</volume>
<numero>April</numero>
<issue>April</issue>
<page-range>2521-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bodey]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Buckley]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sathe]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[Ph]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Leukocytes and Infection in Patients with Acute Leukemia]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>1966</year>
<volume>64</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>328-42</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flowers]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Seidenfeld]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bow]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Karten]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gleason]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hawley]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy American Society of Clinical Oncology Clinical Practice Guideline]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2019</year>
<volume>31</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>794-810</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cuervo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Bermúdez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Arroyo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutropenia febril en el trópico una descripción de los hallazgos clínicos y microbiológicos y el impacto de la terapia inapropiada que utilizan en un centro de referencia oncológica en Colombia]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2012</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Madrid]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Combariza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gálvez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Olaya]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de la neutropenia febril en pacientes adultos con neoplasia hematológica, en un período de 26 meses en el Hospital Pablo Tobón Uribe, Colombia]]></article-title>
<source><![CDATA[Rev Chil infectología]]></source>
<year>2013</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>195-201</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freifeld]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Bow]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sepkowitz]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Boeckh]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Mullen]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer 2010 Update by the Infectious Diseases Society of America]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2011</year>
<volume>52</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e56-93</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Giardin]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Noguerado Asensio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bacteriemias]]></article-title>
<source><![CDATA[An Med Interna]]></source>
<year>2005</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>105-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Evans]]></surname>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ost]]></surname>
</name>
<name>
<surname><![CDATA[David]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pneumonia in the neutropenic cancer patient]]></article-title>
<source><![CDATA[Curr Opin Pulm Med]]></source>
<year>2015</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>260-71</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tancheva]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[S , et al. Infections in urinary tract of patients with haematological malignancies undergoing antineoplastic therapy]]></article-title>
<collab>S.Micheva.I.Marinova.I.Bojchev.B.Marinov.M.Nenov.K</collab>
<source><![CDATA[JofIMAB]]></source>
<year>2009</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>95-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rolston]]></surname>
<given-names><![CDATA[KVI]]></given-names>
</name>
<name>
<surname><![CDATA[Bodey]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Safdar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polymicrobial Infection in Patients with Cancer An Underappreciated and Underreported Entity]]></article-title>
<source><![CDATA[Clin Infec Dis]]></source>
<year>2007</year>
<volume>45</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>228-33</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<collab>NHI</collab>
<source><![CDATA[Oral Complications of Cancer and Cancer Therapy: From Cancer Treatment to Survivorship Oral Complications of Cancer and Cancer Therapy From Cancer Treatment to Survivorship]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pulia]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Calderone]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Meister]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Santistevan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[May]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update on management of skin and soft tissue infections in the emergency department]]></article-title>
<source><![CDATA[Curr Infect Dis Rep]]></source>
<year>2014</year>
<volume>16</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>418-27</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabagliati]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bertín]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cerón]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de neutropenia febril en pacientes adultos con leucemia aguda y linfoma Estudio de cohorte en hospitales público y privado de Santiago, Chile]]></article-title>
<source><![CDATA[Rev Chil Infectol]]></source>
<year>2012</year>
<volume>31</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>721-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ricardo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ávila]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Febrile neutropenia after cytostatic therapy observed in the Institute of Oncology and Radiobiology]]></article-title>
<source><![CDATA[Rev Cub Farm]]></source>
<year>2016</year>
<volume>50</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>44-52</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabagliati Ricardo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Fuentes Gino]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Orellana Eric]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Oporto Jorge]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez Isabel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile]]></article-title>
<collab>Benítez G Rosana et al</collab>
<source><![CDATA[Rev Chil Infectol]]></source>
<year>2009</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>106-13</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schimpff]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[VMAE]]></given-names>
</name>
<name>
<surname><![CDATA[Ph]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Vermeulen]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Moody]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Origin of Infection in Acute Non-lymphocytic Leukemia Significance of Hospital Acquisition of Potential Pathogens]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>1972</year>
<volume>77</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>707-14</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
